News & Events

• November 29, 2023
  

  C-Path’s Translational Therapeutics Accelerator and Celdara Medical Announce Pipeline-focused MOU

  TUCSON, Ariz. and LEBANON, N.H., November 29, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need. Under the terms of this agreement, both organizations look to...
• November 9, 2023
  

  C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies

  TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a Multi-disease Area Workshop,” now published in Neurotherapeutics, The Journal of the American Society for Experimental Neurotherapeutics. A distinguished team of C-Path scientists and patient-advocates...
• November 8, 2023
  

  C-Path Partners with Unite4TB to Create a New Dawn in the Fight Against Tuberculosis

  C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the AMR Accelerator.  A new dawn in the fight against Tuberculosis UNITE4TB, the largest public-private collaboration in tuberculosis drug development, announces start of clinical trials    8 November 2023. Today, UNITE4TB, an international public-private partnership...
• November 7, 2023
  

  C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology

  Research confirms immune-based therapies improve outcomes in new-onset T1D TUCSON, Ariz., November 7, 2023 — Critical Path Institute’s (C-Path) Type 1 Diabetes Consortium, along with external collaborators from Cardiff University and the University of Alberta, today announced the publishing of “C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes”...
• October 30, 2023
  

  eCOA Consortium Announces Publication of an Open Access Article

  C-Path’s eCOA Consortium is pleased to announce the publication of an open access article in Value in Health titled “Best Practices for the Electronic Implementation and Migration of Patient-Reported Outcome Measures.” This article builds upon existing best practices for the electronic migration and implementation of patient-reported outcome measures to provide a comprehensive single point of...